InsidersTradesSigma
申报总数
公司
▲ 买入（4 笔）
▼ 卖出（0 笔）
内部人交易记录
首席财务官已披露买入
4
已披露卖出
0
T+90 胜率
50%
T+90 平均收益
+6.6%
基于 2 个已确定 T+90 收益的买入信号。收益基准：公布次日的收盘价。
信号历史
Discover the full record of transactions filed by Kelly Timothy Edwin, 首席财务官. Officer active across 1 company, notably Praxis Precision Medicines, Inc.. Aggregated, 20 disclosures have been recorded. Split: 4 buys · 0 sell. Total volume traded: €94k. History available since 31 August 2021. The latest transaction was filed on 12 January 2026 (Retenue fiscale). Regulator: SEC (Form 4). The full history is accessible without signup.
Companies and markets linked to Kelly Timothy Edwin
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报20 总计
943 股@ US$275.7451.5% 占其流量Common StockSEC:0001863297-26-000005:0
8,800 股0Common StockSEC:0001689548-26-000011:0
139 股@ US$292.638.0% 占其流量Common StockSEC:0001863297-26-000002:0
384 股@ US$31.625.9% 占其流量Common StockSEC:0001104659-25-115100:0
249 股@ US$31.5353.1% 占其流量Common StockSEC:0001689548-25-000065:0
12,500 股0Common StockSEC:0001689548-25-000014:0
139 股@ US$77.524.5% 占其流量Common StockSEC:0001689548-25-000005:0
205 股@ US$37.403.2% 占其流量Common StockSEC:0001104659-24-120746:0
7,800 股0Common StockSEC:0001104659-24-084502:0
606 股@ US$12.3683.0% 占其流量Common StockSEC:0001689548-24-000064:0
139 股@ US$25.191.4% 占其流量Common StockSEC:0001689548-24-000008:0
11,683 股@ US$0.8844.1% 占其流量Common StockSEC:0001689548-23-000092:0
8,000 股@ US$0.87472.8% 占其流量Common StockSEC:0001104659-23-042818:0
标准退出：2023年6月22日 (T+90)
8,000 股@ US$0.87472.8% 占其流量Common StockSEC:0001104659-23-037021:0
标准退出：2023年6月22日 (T+90)
2,079 股@ US$2.522.2% 占其流量Common StockSEC:0001689548-23-000005:0
5 股@ US$1.8110.0% 占其流量Common StockSEC:0001689548-22-000129:0
10,000 股@ US$1.7653.9% 占其流量Common StockSEC:0001689548-22-000078:0
标准退出：2022年9月7日 (T+90)
2,585 股@ US$8.7985.1% 占其流量Common StockSEC:0001689548-22-000042:0
24,000 股0Common StockSEC:0001104659-22-003155:0
3,905 股@ US$19.4815.1% 占其流量Common StockSEC:0001689548-21-000083:0
标准退出：2021年11月29日 (T+90)
20 条申报中的 20 条
About Kelly Timothy Edwin
Kelly Timothy Edwin is Chief Financial Officer at Praxis Precision Medicines, Inc. (XNAS). He has 20 filings in total, and across the 20 recent sampled filings observed between 2021-09-02 and 2026-01-13, buy transactions amount to EUR 93947, with no sells; the most frequent transaction nature is Attribution.
